4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-037544
Co-Chief Executive Officer sold 15,500 shares at $14.69 ($227,618)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Klee Justin B. Co-Chief Executive Officer | 2026-02-02 | Sale | −15,500 | $14.69 | $227,618 | 3,363,898 | D: show line 1 in the form |
| Open-market sales · 15,500 sh · avg $14.69 · $227,618 | |||||||
Loading xslF345X05/ownership.xml…